During the past decade, CancerCare Manitoba; Neuro-Oncology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CancerCare Manitoba; Neuro-Oncology" #1 collaborator was "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "CancerCare Manitoba; Neuro-Oncology" are "Breast Cancer" (1 trials), "Glioblastoma" (1 trials) and "Hemophilia A" (1 trials). Many other conditions were trialed in "CancerCare Manitoba; Neuro-Oncology" in a lesser frequency.

Most popular intervention types in "CancerCare Manitoba; Neuro-Oncology" are "Drug" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "5-Fluorouracil" (1 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "CancerCare Manitoba; Neuro-Oncology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "CancerCare Manitoba; Neuro-Oncology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CancerCare Manitoba; Neuro-Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CancerCare Manitoba; Neuro-Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".